# DECOY THERAPEUTICS INC (DCOY)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DCOY/

- Reporting holders: 4
- Reported value: $31.0K
- Shares held by institutions: 4,317 of 655,185 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [VANGUARD CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/2100119-vanguard-capital-management-llc/) | $29.0K | 4,034 | 0.0% | 1 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $1.8K | 256 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $180 | 25 | 0.0% | 2 |
| [Caitong International Asset Management Co., Ltd](https://holderbook.com/funds/1963355-caitong-international-asset-management-co-ltd/) | $14 | 2 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 4 | $31.0K |
| Q1 2026 | 4 | $10.5K |
| Q4 2025 | 9 | $51.4K |
| Q3 2025 | 5 | $2.0K |